A majority of the revenues of the company come through the Animal Feed Business of the company. The company holds a dominant place in the industry of animal feed. The innovation in its produce of animal feed with all the appropriate nutrients makes the feed that this company produces a winner and in great demand by the agriculture sector as a whole. Its research labs are what makes the company and its produce work and thrive, helping farmers across India improve farm productivity and overall agricultural quality. 

For more than two decades, CRISIL has been providing short-term ratings to commercial paper, which is a type of unsecured debt instrument that corporations issue with a short-term maturity. CRISIL Ratings has reaffirmed its 'CRISIL A1+' rating on the commercial paper of Godrej Agrovet Ltd (GAL) on May 25, 2022.

Although the past year’s returns (-14.19%) have been in the negative, the returns for the near and shorter term (1 month = +.31%) are starting to look positive. Having said that, the long-term outlook for any stock cannot be predicted as a number of factors like price performance, market volatility, inflation and other variables play their part in determining the long-term outlook. 

Net profit of Godrej Agrovet has increased from March 2019 when it was at 337.22 crores to March 2022 when profit was at 368.94 crores. In 202o and 2021, net profits were down from both these numbers. 

The debt-to-equity ratio of Godrej Agrovet stocks is 0.69 (March 2022). 

The EBITDA margin of Godrej Agrovet for March 2022 is 0.0801111. 

The potential factors or catalysts that could impact any stock price could be demand factors of the product the company produces. In terms of Godrej Agrovet, the demand for animal feed, oil palm, dairy and processed foods, and crop protection methods that the company produces could yield potential positive stock yields.